Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models

References

• Aguilar, E. G., and W. J. Murphy. 2018. Obesity induced T cell dysfunction and implications for cancer immunotherapy. Curr. Opin. Immunol. 51:181–86. doi:10.1016/j.coi.2018.03.012.Obesity.
   PubMed Web of Science ®Google Scholar
• Aguilar, M., T. Bhuket, S. Torres, B. Liu, and R. J. Wong. 2015. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 313 (19):1973–74. doi:10.1001/jama.2015.4260.
   PubMed Web of Science ®Google Scholar
• Alaraby, M., B. Annangi, R. Marcos, and A. Hernánde. 2016. Drosophila melanogaster as a suitable in vivo model to determine potential side effects of nanomaterials: A review. J. Toxicol. Environ. Health B 19:65–104. doi:10.1080/10937404.2016.1166466.
   PubMed Web of Science ®Google Scholar
• Andersen, C. J., K. E. Murphy, and M. L. Fernandez. 2016. Impact of obesity and metabolic syndrome on immunity. Adv. Nutr. 7:66–75. doi:10.3945/an.115.010207.66.
   PubMed Web of Science ®Google Scholar
• Anto, J. M., P. Vermeire, J. Vestbo, and J. Sunyer. 2001. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J. 17:982–94. doi:10.1183/09031936.01.17509820.
   PubMed Web of Science ®Google Scholar
• Beltrán-Sánchez, H., M. O. Harhay, M. M. Harhay, and S. McElligott. 2013. Prevalence and trends of metabolic syndrome in the adult US population, 1999–2010. J. Am. Coll. Cardiol. 62:697–703. doi:10.1016/j.jacc.2013.05.064.Prevalence.
   PubMed Web of Science ®Google Scholar
• Benn, T., and B. Cavanagh. 2010. The release of nanosilver from consumer products used in the home. J. Environ. Qual. 39:1875–82. doi:10.2134/jeq2009.0363.
   PubMed Web of Science ®Google Scholar
• Bergin, I. L., L. A. Wilding, M. Morishita, K. Walacavage, A. P. Ault, J. L. Axson, D. I. Stark, S. A. Hashway, S. S. Capracotta, P. R. Leroueil, et al. 2016. Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model. Nanotoxicology 10:352–60. doi:10.3109/17435390.2015.1072588.
   PubMed Web of Science ®Google Scholar
• Beyer, M., Z. Abdullah, J. M. Chemnitz, D. Maisel, J. Sander, C. Lehmann, Y. Thabet, P. V. Shinde, L. Schmidleithner, M. Köhne, et al. 2016. Tumor-necrosis factor impairs CD4 + T cell – Mediated immunological control in chronic viral infection. Nat. Immunol. 17:593–603. doi:10.1038/ni.3399.
   PubMed Web of Science ®Google Scholar
• Bieghs, V., and C. Trautwein. 2013. The innate immune response during liver inflammation and metabolic disease. Trends Immunol. 34:446–52. doi:10.1016/j.it.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Buttorff, C., T. Ruder, and M. Bauman. 2017. Multiple chronic conditions in the United States. Rand. Online only. doi:10.7249/TL221
   Google Scholar
• Cao, K., J. Xu, X. Zou, Y. Li, C. Chen, A. Zheng, H. Li, H. Li, I. M.-Y. Szeto, Y. Shi, et al. 2014. Free radical biology and medicine hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radical Biol. Med. 67:396–407. doi:10.1016/j.freeradbiomed.2013.11.029.
   PubMed Web of Science ®Google Scholar
• Chaloupka, K., Y. Malam, and A. M. Seifalian. 2010. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28:580–88. doi:10.1016/j.tibtech.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Chang, H., T. Hsiao, C. Wu, H. Chang, C. Lee, C. Chang, and T. Cheng. 2013. Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models. Int. J. Nanomedicine 8:4495–506. doi:10.2147/IJN.S52239.
   PubMed Web of Science ®Google Scholar
• Chen, H., M. S. Goldberg, and P. J. Villeneuve. 2008. A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases. Rev. Environ. Health. 23:243–91. doi:10.1515/reveh.2008.23.4.243.
   PubMedGoogle Scholar
• Chen, J., and J. Schwartz. 2008. Metabolic syndrome and inflammatory responses to long-term particulate air pollutants. Environ. Health Perspect. 116:612–17. doi:10.1289/ehp.10565.
   PubMed Web of Science ®Google Scholar
• Chen, R., L. Zhao, R. Bai, Y. Liu, L. Han, Z. Xu, F. Chen, H. Autrup, D. Long, and C. Chen. 2016. Silver nanoparticles induced oxidative and endoplasmic reticulum stresses in mouse tissues: Implications for the development of acute toxicity after intravenous administration. Toxicol. Res. (Camb) 1:602–08. doi:10.1039/c5tx00464k.
   Google Scholar
• Chugh, B. P., J. P. Lerch, L. X. Yu, M. Pienkowski, R. V. Harrison, R. M. Henkelman, and J. G. Sled. 2009. NeuroImage measurement of cerebral blood volume in mouse brain regions using micro-computed tomography. NeuroImage 47:1312–18. doi:10.1016/j.neuroimage.2009.03.083.
   PubMed Web of Science ®Google Scholar
• Chugh, H., D. Sood, I. Chandra, V. Tomar, G. Dhawan, and R. Chandra. 2018. Role of gold and silver nanoparticles in cancer nano-medicine. Artif. Cells Nanomed. Biotechnol. 46:1210–20. doi:10.1080/21691401.2018.1449118.
   PubMed Web of Science ®Google Scholar
• Cirillo, P., W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R. J. Johnson. 2006. Uric acid, the metabolic syndrome, and renal disease. J. Am. Soc. Nephrol. 17:165–68. doi:10.1681/ASN.2006080909.
   PubMed Web of Science ®Google Scholar
• Dabass, A., E. O. Talbott, J. R. Rager, G. M. Marsh, A. Venkat, F. Holguin, and R. K. Sharma. 2018. Systemic inflammatory markers associated with cardiovascular disease and acute and chronic exposure to fine particulate matter air pollution (PM2. 5) among US NHANES adults with metabolic syndrome. Environ. Res. 161:485–91. doi:10.1016/j.envres.2017.11.042.
   PubMed Web of Science ®Google Scholar
• Desroches, S., and B. Lamarche. 2007. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32:23–32. doi:10.1139/H06-095.
   PubMed Web of Science ®Google Scholar
• Devlin, R. B., C. B. Smith, M. T. Schmitt, A. G. Rappold, A. Hinderliter, and D. Graff. 2014. Controlled exposure of humans with metabolic syndrome to concentrated ultrafine ambient particulate matter causes cardiovascular effects. Toxicol. Sci. 140:61–72. doi:10.1093/toxsci/kfu063.
   PubMed Web of Science ®Google Scholar
• Dunn, K., and V. Edwards-Jones. 2004. The role of acticoatTM with nanocrystalline silver in the management of burns. Burns 30:S1–S9. doi:10.1016/j.burns.2004.06.000.
   PubMed Web of Science ®Google Scholar
• Dziendzikowska, K., J. Gromadzka-ostrowska, A. Lankoff, M. Oczkowski, A. Krawczy, J. Chwastowska, M. Sadowska-bratek, E. Chajduk, M. Wojewódzka, and M. Du. 2012. Time-dependent biodistribution and excretion of silver nanoparticles in male wistar rats. J App Toxicol. 32:920–28. doi:10.1002/jat.2758.
   PubMed Web of Science ®Google Scholar
• Echegoyen, Y., and C. Nerín. 2013. Nanoparticle release from nano-silver antimicrobial food containers. Food Chem. Toxicol. 62:16–22. doi:10.1016/j.fct.2013.08.014.
   PubMed Web of Science ®Google Scholar
• Eom, H., and J. Choi. 2010. P38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in jurkat T cells. Environ. Sci. Technol. 44:8337–42. doi:10.1021/es1020668.
   PubMed Web of Science ®Google Scholar
• Esser, N., S. Legrand-poels, J. Piette, J. Scheen, and N. Paquot. 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105:141–50. doi:10.1016/j.diabres.2014.04.006.
   PubMed Web of Science ®Google Scholar
• Ford, E. S., W. H. Giles, and A. H. Mokdad. 2004. Increasing prevalence of the metabolic syndrome among U.S adults. Diabetes Care 27:2444–49. doi:10.2337/diacare.27.10.2444.
   PubMed Web of Science ®Google Scholar
• Galassi, A., K. Reynolds, and J. He. 2006. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am. J. Med. 119:812–19. doi:10.1016/j.amjmed.2006.02.031.
   PubMed Web of Science ®Google Scholar
• Ge, L., Q. Li, M. Wang, J. Ouyang, X. Li, and M. Q. M. Xing. 2014. Nanosilver particles in medical applications: Synthesis, performance, and toxicity. Int. J. Nanomedicine 9:2399–407. doi:10.2147/IJN.S55015.
   PubMed Web of Science ®Google Scholar
• Genter, M. B., N. C. Newman, S. G. Howard, S. F. Ali, and B. Bolton. 2012. Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol. Pathol. 40:1004–13. doi:10.1177/0192623312444470.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Carter, D. A., B. F. Leo, P. Ruenraroengsak, S. Chen, A. E. Goode, I. G. Theodorou, K. F. Chung, R. Carzaniga, M. S. P. Shaffer, D. T. Dexter, et al. 2017. Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes. Sci. Rep. 7:1–14. doi:10.1038/srep42871.
   PubMed Web of Science ®Google Scholar
• Gottipolu, R. R., J. G. Wallenborn, E. D. Karoly, M. C. Schladweiler, A. D. Ledbetter, T. Krantz, W. P. Linak, A. Nyska, J. A. Johnson, R. Thomas, et al. 2009. One-month diesel exhaust inhalation produces hypertensive gene expression pattern in healthy rats. Environ. Health Perspect. 117:38–46. doi:10.1289/ehp.11647.
   PubMed Web of Science ®Google Scholar
• Green, W. D., and M. A. Beck. 2017. Obesity altered T cell metabolism and the response to infection. Curr. Opin. Immunol. 46:1–7. doi:10.1016/j.coi.2017.03.008.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M. 2006. Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 47:1093–100. doi:10.1016/j.jacc.2005.11.046.
   PubMed Web of Science ®Google Scholar
• Haan, J. M. M. D., and G. Kraal. 2012. Innate immune functions of macrophage subpopulations in the spleen. J. Innate Immun. 4:437–45. doi:10.1159/000335216.
   PubMed Web of Science ®Google Scholar
• Haase, A., J. Tentschert, H. Jungnickel, P. Graf, A. Mantion, F. Draude, J. Plandl, M.E. Goetz, S. Galla, A. Mašić. 2011. Toxicity of silver nanoparticles in human macrophages: Uptake, intracellular distribution and cellular responses. J. Phys. Conf. Ser. 304:1–14. doi:10.1088/1742-6596/304/1/012030.
   Google Scholar
• Hackenberg, S., A. Scherzed, M. Kessler, S. Hummel, A. Technau, K. Froelich, C. Ginzkey, C. Koehler, R. Hagen, and N. Kleinsasser. 2011. Silver nanoparticles: Evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett. 201:27–33. doi:10.1016/j.toxlet.2010.12.001.
   PubMed Web of Science ®Google Scholar
• Haffner, S. M. 2006. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97:2–11. doi:10.1016/j.amjcard.2005.11.010.
   Web of Science ®Google Scholar
• Halpin, H. A., M. M. Morales-suárez-varela, and J. M. Martin-moreno. 2010. Chronic disease prevention and the new public health. Public Health Rev. 32:120–54. doi:10.1007/BF03391595.
   Google Scholar
• Isomaa, B., P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M. Taskinen, and L. Groop. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–89. doi:10.2337/diacare.24.4.683.
   PubMed Web of Science ®Google Scholar
• Javidi, J., A. Haeri, F. Nowroozi, and S. Dadashzadeh. 2019. Pharmacokinetics, tissue distribution and excretion of Ag2S quantum dots in mice and rats: The effects of injection dose, particle size and surface charge. Pharm. Res. 36:1–16. doi:10.1007/s11095-019-2571-1.
   Web of Science ®Google Scholar
• Johanson, G., and U. Carlander. 2016. Uptake and biodistribution of nanoparticles–a review. Kemi Swedish Chemicals Agency.
   Google Scholar
• Jong, W. H. D., L. T. M. Van Der Ven, A. Sleijffers, M. V. D. Z. Park, E. H. J. M. Jansen, H. Van Loveren, and R. J. Vandebriel. 2013. Biomaterials systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials 34:8333–43. doi:10.1016/j.biomaterials.2013.06.048.
   PubMed Web of Science ®Google Scholar
• Kaweeteerawat, C., P. N. Ubol, S. Sangmuang, S. Aueviriyavit, and R. Maniratanachote. 2017. Mechanisms of antibiotic resistance in bacteria mediated by silver nanoparticles. J. Toxicol. Environ. Health A 80:1276–89. doi:10.1080/15287394.2017.1376727.
   PubMed Web of Science ®Google Scholar
• Kennedy, A. J., K. L. J. Ellacott, V. L. King, and A. H. Hasty. 2010. Mouse models of the metabolic syndrome. Dis. Model. Mech. 3:156–66. doi:10.1242/dmm.003467.
   PubMed Web of Science ®Google Scholar
• Kermanizadeh, A., I. Gosens, L. MacCalman, H. Johnston, P. H. Danielsen, N. R. Jacobsen, A.-G. Lenz, T. Frenandes, R. Scins, F. R. Cassee, et al. 2016. A multilaboratory toxicological assessment of a panel of 10 engineered nanomaterials to human health- the highlights, limitations, and current and future challenges. J. Toxicol. Environ. Health B 19:1–28. doi:10.1080/10937404.2015.1126210.
   PubMed Web of Science ®Google Scholar
• Kim, C. H., and Z. M. Younossi. 2008. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome. Cleve Clin. J. Med. 74:721–28. doi:10.3949/ccjm.75.10.721.
   Google Scholar
• Lam, P. K., E. S. Y. Chan, W. S. Ho, and C. T. Liew. 2004. In vitro cytotoxicity testing of a nanocrystalline silver dressing (acticoat) on cultured keratinocytes. Br. J. Biomed. Sci. 61:125–27. doi:10.1080/09674845.2004.11732656.
   PubMed Web of Science ®Google Scholar
• Lee, C. L. D., S. B. Fashir, M. L. Castilho, M. A. Hupman, L. J. Raniero, I. Alwayn, and K. C. Hewitt. 2016. Epidermal growth factor receptor-specific nanoprobe biodistribution in mouse models. J. Pharm. Sci. 105:25–30. doi:10.1016/j.xphs.2015.10.005.
   PubMed Web of Science ®Google Scholar
• Lee, J. H., Y. S. Kim, K. S. Song, H. R. Ryu, J. H. Sung, J. D. Park, H. M. Park, N. Song, B. Shin, D. Marshak, et al. 2013. Biopersistence of silver nanoparticles in tissues from sprague–dawley rats. Part Fibre Toxicol. 10:1–14. doi:10.1186/1743-8977-10-36.
   PubMed Web of Science ®Google Scholar
• Lteif, A. A., K. Han, and K. J. Mather. 2005. Obesity, insulin resistance, and the metabolic syndrome determinants of endothelial dysfunction in whites and blacks. Circulation 112:32–38. doi:10.1161/CIRCULATIONAHA.104.520130.
   PubMed Web of Science ®Google Scholar
• Mahdy, M. M. E., T. A. S. Ahmed, H. S. Aly, F. F. Mohammed, and M. I. Shaalan. 2014. Evaluation of hepatotoxic and genotoxic potential of silver nanoparticles in albino rats. Exp. Toxicol. Pathol. 67:21–29. doi:10.1016/j.etp.2014.09.005.
   PubMedGoogle Scholar
• Martins, A. C., Jr, L. F. Azevedo, C. C. S. Rocha, M. F. H. Carneiro, V. P. Venancio, M. R. Almeida, L. M. G. Antunes, R. C. Hott, J. L. Rodrigues, A. T. Ogunjimi, et al. 2017. Evaluation of distribution, redox parameters, and genotoxicity in wistar rats co-exposed to silver and titanium dioxide nanoparticles. J. Toxicol. Environ. Health A 80:1156–65. doi:10.1080/15287394.2017.1357376.
   PubMed Web of Science ®Google Scholar
• Meng, J., Y. Ji, J. Liu, X. Cheng, H. Guo, W. Zhang, X. Wu, and H. Xu. 2014. Using gold nanorods core/silver shell nanostructures as model material to probe biodistribution and toxic effects of silver nanoparticles in mice. Nanotoxicology 8:686–96. doi:10.3109/17435390.2013.822593.
   PubMed Web of Science ®Google Scholar
• Paddle-Ledinek, J. E., Z. Nasa, and H. J. Cleland. 2006. Effect of different wound dressings on cell viability and proliferation. Plast. Reconstr. Surg. 117:110S–118S. doi:10.1097/01.prs.0000225439.39352.ce.
   PubMed Web of Science ®Google Scholar
• Paoletti, R., C. Bolego, A. Poli, and A. Cignarella. 2006. Metabolic syndrome, inflammation and atherosclerosis. Vasc. Health Risk Manag. 2:145–52. doi:10.2147/vhrm.2006.2.2.145.
   PubMedGoogle Scholar
• Park, E., E. Bae, J. Yi, Y. Kim, K. Choi, S. Hee, J. Yoon, B. Chun, and K. Park. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 30:162–68. doi:10.1016/j.etap.2010.05.004.
   PubMed Web of Science ®Google Scholar
• Park, K., and Y. Lee. 2013. The stability of citrate-capped silver nanoparticles in isotonic glucose solution for intravenous injection. J. Toxicol. Environ. Health A 76:1236–45. doi:10.1080/15287394.2013.849215.
   PubMed Web of Science ®Google Scholar
• Park, M. V. D. Z., A. M. Neigh, J. P. Vermeulen, L. J. J. De, H. W. Verharen, J. J. Briedé, H. Van Loveren, and W. H. De Jong. 2011. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 32:9810–17. doi:10.1016/j.biomaterials.2011.08.085.
   PubMed Web of Science ®Google Scholar
• Pettersson, U. S., T. B. Walde, P. Carlsson, L. Jansson, and M. Phillipson. 2012. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS ONE 7:1–10. doi:10.1371/journal.pone.0046057.
   Web of Science ®Google Scholar
• Poon, V. K. M., and A. Burd. 2004. In vitro cytotoxicity of silver: Implication for clinical wound care. Burns 30:140–47. doi:10.1016/j.burns.2003.09.030.
   PubMed Web of Science ®Google Scholar
• Pou, K. M., J. M. Massaro, U. Hoffman, K. Lieb, R. S. Vasan, C. J. O’Donnell, and C. S. Fox. 2009. Patterns of abdominal fat distribution. Diabetes Care 32:481–85. doi:10.2337/dc08-1359.
   PubMed Web of Science ®Google Scholar
• Pratsinis, A., P. Hervella, J. Leroux, and S. E. Pratsinis. 2013. Toxicity of silver nanoparticles in macrophages. Small 9:2576–84. doi:10.1002/smll.201202120.
   PubMed Web of Science ®Google Scholar
• Rael, E. L., and R. F. Lockey. 2011. Interleukin-13 signaling and its role in asthma. World Allergy Organ. J. 4:54–64. doi:10.1097/WOX.0b013e31821188e0.
   PubMedGoogle Scholar
• Rahman, M. F., J. Wang, T. A. Patterson, U. T. Saini, B. L. Robinson, G. D. Newport, R. C. Murdock, J. J. Schlager, S. M. Hussain, and S. F. Ali. 2009. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 187:15–21. doi:10.1016/j.toxlet.2009.01.020.
   PubMed Web of Science ®Google Scholar
• Ramadi, K. B., Y. A. Mohamed, A. Al-sbiei, S. Almarzooqi, G. Bashir, A. Al-Dhanhani, D. Sarawathiamma, S. Qadri, J. Yasin, A. Nemmar, et al. 2016. Acute systemic exposure to silver-based nanoparticles induces hepatotoxicity and NLRP3-dependent inflammation. Nanotoxicology 10:1061–74. doi:10.3109/17435390.2016.1163743.
   PubMed Web of Science ®Google Scholar
• Rector, R. S., J. P. Thyfault, Y. Wei, and J. A. Ibdah. 2008. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J. Gastroenterol. 14:185–92. doi:10.3748/wjg.14.185.
   PubMed Web of Science ®Google Scholar
• Rincón, B. M., J. Anguita, T. Nakamura, E. Fikrig, and R. A. Flavell. 1997. Interleukin (IL)-6 directs the differentiation of IL-4–producing CD4+ T cells. J. Exp. Med. 185:461–70. doi:10.1084/jem.185.3.461.
   PubMed Web of Science ®Google Scholar
• Roberts, C. K., A. L. Hevener, and R. J. Barnard. 2013. Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training. Compr. Physiol. 3:1–58. doi:10.1002/cphy.c110062.Metabolic.
   PubMed Web of Science ®Google Scholar
• Rosario, F., P. Hoet, A. J. A. Nogueira, C. Santos, and H. Oliveira. 2018. Differential pulmonary in vitro toxicity of two small-sized polyvinylpyrrolidone-coated silver nanoparticles. J. Toxicol. Environ. Health A 81:675–90. doi:10.1080/15287394.2018.1468837.
   PubMed Web of Science ®Google Scholar
• Sanchez-Guzman, D., P. Le, B. Villeret, N. Sola, R. Le, A. Guyard, A. Kemmel, B. Crestani, J. Sallenave, and I. Garcia-verdugo. 2019. Biomaterials silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity. Biomaterials 217:1–14. doi:10.1016/j.biomaterials.2019.119308.
   Web of Science ®Google Scholar
• Sardari, R. R. R., S. R. Zarchi, A. Talebi, S. Nasri, S. Imani, A. Khoradmehr, and S. A. R. Sheshde. 2012. Toxicological effects of silver nanoparticles in rats. Afr. J. Microbiol. Res. 6:5587–93. doi:10.5897/AJMR11.1070.
   Google Scholar
• Snyder, R. W., T. R. Fennell, C. J. Wingard, N. P. Mortensen, N. A. Holland, J. H. Shannahan, W. Pathmasiri, A. H. Lewin, and S. C. J. Sumner. 2016. Distribution and biomarker of carbon-14 labeled fullerene C60 ([14C(U)]C60) in pregnant and lactating rats and their offspring after maternal intravenous exposure. J App Toxicol. 35:1438–51. doi:10.1002/jat.3177.Distribution.
   Web of Science ®Google Scholar
• Song, J. Y., and B. S. Kim. 2009. Rapid biological synthesis of silver nanoparticles using plant leaf extracts. Bioprocess Biosyst. Eng. 32:79–84. doi:10.1007/s00449-008-0224-6.
   PubMed Web of Science ®Google Scholar
• Sumner, S. C. J., R. W. Snyder, C. Wingard, N. P. Mortensen, N. A. Holland, J. H. Shannahan, S. Dhungana, W. Pathmasiri, A. H. Lewin, and T. R. Fennell. 2016. Distribution and biomarkers of carbon-14 labeled fullerene C60 ([14C(U)]C60) in female rats and mice for up to 30 days after intravenous exposure. J App Toxicol. 35:1452–64. doi:10.1002/jat.3110.Distribution.
   Web of Science ®Google Scholar
• Sun, B., and M. Karin. 2012. Obesity, inflammation, and liver cancer. J. Hepatol. 56:704–13. doi:10.1016/j.jhep.2011.09.020.
   PubMed Web of Science ®Google Scholar
• Taha, E., F. Djouider, and E. Banoqitah. 2019. Monte Carlo simulation of dose enhancement due to silver nanoparticles implantation in brain tumor brachytherapy using a digital phantom. Radiat. Phys. Chem. 156:15–21. doi:10.1016/j.radphyschem.2018.10.027.
   Web of Science ®Google Scholar
• Takenaka, S., E. Karg, C. Roth, H. Schulz, A. Ziesenis, U. Heinzmann, P. Schramel, and J. Heyder. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 109:547–51. doi:10.1289/ehp.01109s4547.
   PubMed Web of Science ®Google Scholar
• Tang, J., L. Xiong, S. Wang, J. Wang, L. Liu, J. Li, Z. Wan, and T. Xi. 2008. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl. Surf. Sci. 255:502–04. doi:10.1016/j.apsusc.2008.06.058.
   Web of Science ®Google Scholar
• Tang, J., L. Xiong, S. Wang, J. Wang, L. Liu, L. Jiage, F. Yuan, and X. Tingfei. 2009. Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol. 9:4924–32. doi:10.1166/jnn.2009.1269.
   PubMed Web of Science ®Google Scholar
• Tran, Q. H., V. Q. Nguyen, and A. Le. 2013. Silver nanoparticles: Synthesis, properties, toxicology, applications and perspectives. Adv. Nat. Sci.: Nanosci. Nanotechnol. 4:1–20.
   Web of Science ®Google Scholar
• Trickler, W. J., S. M. Lantz, R. C. Murdock, A. M. Schrand, B. L. Robinson, G. D. Newport, J. J. Schlager, S. J. Oldenburg, M. G. Paule, W. Slikker, et al. 2010. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci. 118:160–70. doi:10.1093/toxsci/kfq244.
   PubMed Web of Science ®Google Scholar
• Wagner, J. G., K. Allen, H. Yang, B. Nan, M. Morishita, and B. Mukherjee. 2014. Cardiovascular depression in rats exposed to inhaled particulate matter and ozone: Effects of diet-induced metabolic syndrome. Environ. Health Perspect. 122:27–33. doi:10.1289/ehp.1307085.
   PubMed Web of Science ®Google Scholar
• Wang, Q., W. Pan, Y. Liu, J. Luo, D. Zhu, Y. Lu, X. Feng, J. P. Gigley, and M. A. Franco. 2018. Hepatitis B virus-specific CD8+ T cells maintain functional exhaustion after antigen reexposure in an acute activation immune environment. Front. Immunol. 9:1–14. doi:10.3389/fimmu.2018.00219.
   PubMed Web of Science ®Google Scholar
• Wang, Z., E. G. Aguilar, J. I. Luna, C. Dunai, L. T. Khuat, C. T. Le, A. Mirsoian, C. M. Minnar, K. M. Stoffel, I. R. Sturgill, et al. 2019. Function during tumor progression and PD-1 checkpoint blockade. Nat. Med. 25:141–51. doi:10.1038/s41591-018-0221-5.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., R. Yaginuma, K. Ikejima, and A. Miyazaki. 2008. Liver diseases and metabolic syndrome. J. Gastroenterol. 43:509–18. doi:10.1007/s00535-008-2193-6.
   PubMed Web of Science ®Google Scholar
• Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12:6–13. doi:10.1038/ni.2035.
   Web of Science ®Google Scholar
• Wherry, E. J., and M. Kurachi. 2015. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15:486–99. doi:10.1038/nri3862.
   PubMed Web of Science ®Google Scholar
• Xue, Y., S. Zhang, Y. Huang, T. Zhang, X. Liu, Y. Hu, Z. Zhang, and M. Tang. 2012. Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. J App Toxicol. 32:890–99. doi:10.1002/jat.2742.
   PubMed Web of Science ®Google Scholar
• Yang, L., H. Kuang, W. Zhang, Z. P. Aguilar, H. Wei, and H. Xu. 2017. Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice. Sci. Rep. 7:1–12. doi:10.1038/s41598-017-03015-1.
   PubMed Web of Science ®Google Scholar
• Zande, M. V. D., R. J. Vandebriel, E. V. Doren, E. Kramer, Z. H. Rivera, C. S. Serrano-rojero, E. R. Gremmer, J. Mast, R. J. Peters, P. C. Hollman. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427–42. doi:10.1021/nn302649p.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Z. Liu, W. Shen, and S. Gurunathan. 2016a. Silver nanoparticles: Synthesis, characterization, properties, applications, and therapeutic approaches. Int. J. Mol. Sci. 17:1534. doi:10.3390/ijms17091534.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., W. Poon, A. J. Tavares, I. D. Mcgilvray, and W. C. W. Chan. 2016b. Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination. J. Cont. Rel. 240:332–48. doi:10.1016/j.jconrel.2016.01.02.
   PubMed Web of Science ®Google Scholar